NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

CompletedN/A

Sponsor: Pfizer

Conditions: Renal Cell Carcinoma

The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcome of advanced renal cell carcinoma captured in Taiwan National Health Insurance Research Database.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* advanced/metastatic renal cell carcinoma

Exclusion Criteria:

* N/A